Related Experiment Video
Updated: Jun 18, 2026

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression
Samuel Godar1, Tan A Ince, George W Bell
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Abstract:
The p53 tumor suppressor is a key mediator of cellular responses to various stresses. Here, we show that under conditions of basal physiologic and cell-culture stress, p53 inhibits expression of the CD44 cell-surface molecule via binding to a noncanonical p53-binding sequence in the CD44 promoter. This interaction enables an untransformed cell to respond to stress-induced, p53-dependent cytostatic and apoptotic signals that would otherwise be blocked by the actions of CD44. In the absence of p53 function, the resulting derepressed CD44 expression is essential for the growth and tumor-initiating ability of highly tumorigenic mammary epithelial cells. In both tumorigenic and nontumorigenic cells, CD44's expression is positively regulated by p63, a paralogue of p53. Our data indicate that CD44 is a key tumor-promoting agent in transformed tumor cells lacking p53 function. They also suggest that the derepression of CD44 resulting from inactivation of p53 can potentially aid the survival of immortalized, premalignant cells.
Insights
The p53 tumor suppressor protein inhibits CD44 expression under stress. Loss of p53 function promotes tumor growth by increasing CD44 levels, highlighting CD44 as a tumor promoter.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The p53 tumor suppressor is crucial for cellular stress responses.
- CD44 is a cell-surface molecule involved in cell adhesion and migration.
- Dysregulation of p53 and CD44 is implicated in cancer development.
Purpose of the Study:
- To investigate the regulatory relationship between p53 and CD44 expression.
- To determine the role of CD44 in p53-deficient tumor cells.
- To explore the implications of this interaction in cancer progression.
Main Methods:
- Analysis of p53 binding to the CD44 promoter.
- Measurement of CD44 expression in cells with varying p53 function.
- Assessment of cell growth and tumor-initiating ability.
Main Results:
- p53 directly inhibits CD44 expression by binding to its promoter.
- Loss of p53 function leads to increased CD44 expression.
- Elevated CD44 is essential for the growth of p53-deficient mammary tumor cells.
- CD44 expression is positively regulated by p63, a p53 paralogue.
Conclusions:
- CD44 acts as a tumor promoter in cells lacking p53.
- Inactivation of p53 and subsequent CD44 derepression may facilitate premalignant cell survival.
- Targeting CD44 could be a therapeutic strategy for p53-mutated cancers.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

